Biolase (BIOL) Issues Quarterly Earnings Results
Biolase (NASDAQ:BIOL) issued its earnings results on Wednesday. The medical technology company reported ($0.04) earnings per share for the quarter, hitting the consensus estimate of ($0.04), Bloomberg Earnings reports. Biolase had a negative net margin of 38.56% and a negative return on equity …